Oncology Corporate Profile
Asterias Biotherapeutics is a development stage biotechnology company focusing in regenerative medicine. They are developing therapeutics based on two different platform technologies: pluripotent stem cells and dendritic cell cancer immunotherapy. Near term, they are leveraging these platforms to develop treatments to address significant unmet medical needs in neurology and oncology. These mature programs are focused on de-risked indications and are supported by robust proof-of-concept pre-clinical and clinical data.